Gregory M. Glenn

2019

In 2019, Gregory M. Glenn earned a total compensation of $1.9M as President, Research and Development at Novavax, a 12% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$225,818
Option Awards$819,421
Salary$470,453
Stock Awards$348,306
Other$11,200
Total$1,875,198

Glenn received $819.4K in option awards, accounting for 44% of the total pay in 2019.

Glenn also received $225.8K in non-equity incentive plan, $470.5K in salary, $348.3K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Gregory M. Glenn's compensation ranked 6,257th out of 13,971 executives tracked by ExecPay. In other words, Glenn earned more than 55.2% of executives.

ClassificationRankingPercentile
All
6,257
out of 13,971
55th
Division
Manufacturing
2,355
out of 5,701
59th
Major group
Chemicals And Allied Products
860
out of 2,200
61st
Industry group
Drugs
727
out of 1,886
62nd
Industry
Biological Products, Except Diagnostic Substances
171
out of 389
56th

Pay ratio

Gregory M. Glenn's Pay$1,875,198
Median Employee's Pay$98,413
Pay Ratio

19

to 1

In 2019, the annual total compensation of Gregory M. Glenn was $1,875,198.

The annual total compensation of the median employee at Novavax was $98,413.

The ratio of Gregory M. Glenn's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on May 12, 2020.

Glenn's colleagues

We found three more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2019.

2019

Stanley Erck

Novavax

Chief Executive Officer

2019

John Trizzino

Novavax

Chief Financial Officer

2019

John Herrmann

Novavax

General Counsel

News

You may also like